Report Categories
View AllRecent Articles
View All
American Tower Corporation AMT Outperforms Broad Market Selloff But Faces Structural Headwinds Ahead of Q1 2026 Earnings Release
What Innoviz INVZ management focus reveals about priorities Parabolic 20260506
BUDA Buda Juice management rolls out new organic product lines to boost longterm domestic market share
Lam Research Corporation LRCX MATCH Act Policy Scrutiny Highlights China Exposure Risks Amid Contrasting Valuation and NearTerm Momentum
RoRo Cargo Surge Lifts Gujarat Pipavav Ports Q4 Profit by 27
AIDriven Drug Discovery May Accelerate Treatments for Brain Conditions
Stock Market Holiday This Week BSE NSE Closed on May 28 2026 for Bakri Id
Afentra Secures Operatorship of KON4 Block in Angolas Kwanza Basin
Piper Sandler Raises AbbVie Price Target on IBD Pipeline Advances
RBC Affirms Sector Perform Rating on Ford After EDF Partnership
WLFC Q1 2026 Earnings Strong EPS Surprise of 3537 Outpaces Expectations
BX Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Decline
UFPI Q1 2026 Earnings Earnings Miss Estimate Amid Challenging Conditions
PEBO Q1 2026 Earnings EPS Slightly Misses Consensus as Shares Rise 116
CMMB Q1 2026 Earnings Missed EPS Estimates but Stock Gains on Continued Pipeline Progress
FSP Q4 2025 Earnings Significant EPS Beat Masks Revenue Disclosures
Cellectar Biosciences CLRB Posts Modest Gains as Shares Consolidate Near Resistance
Red Cat Holdings RCAT Jumps 421 as Drone Maker Breaks Past Key Support
Intercure Ltd INCR Rallies 557 as It Approaches Key Resistance Level
IRSA Inversiones IRS Holds Steady at 1504 Key Support and Resistance Levels in Focus
Norwood Financial Corp NWFL Moves Higher as Key Support Holds
Ames National Corporation ATLO Q1 2026 Earnings Solid EPS Beat Amid Stable Operations
ADP Q1 2026 Earnings EPS Beat Amidst Steady Demand for HCM Solutions
TSM Q1 2026 Earnings Strong EPS Beat Signals Robust Demand Amid Cautious Market Response
FHB Q1 2026 Earnings EPS Beats Estimates Amidst Cautious Bank Sector Sentiment
Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development
NVNO Q3 2025 Earnings EPS Beat Signals Progress in Cost Management and Clinical Milestones